Kill kinetics of antimicrobial agents against Helicobacter pylori

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 4, 1996, Pages 719-725

  Flamm, R K ^a   Beyer, J ^a   Tanaka, S K ^a   Clement, J ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

14 HYDROXYCLARITHROMYCIN; AMOXICILLIN; ANTIINFECTIVE AGENT; BISMUTH; CIPROFLOXACIN; CLARITHROMYCIN; METRONIDAZOLE;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HELICOBACTER PYLORI; NONHUMAN; STRAIN DIFFERENCE; TIME;

EID: 0029800959     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.4.719     Document Type: Article

References (12)

1. Cozens, R. M., Toumanen, E., Tosch, W., Zak, O., Suter, J. & Tomasz, A. (1986). Evalution of the bactericideal activity of beta-lactam antimicrobials on slowly growing bacteria cultured in the chemostat. Antimicrobial Agents and Chemotherapy 29, 797-802.
2. Flamm, R. K., Beyer, J., Tanaka, S. K. & Clement, J. (1993). Kill kinetics of five antibiotics against Helicobacter pylori. In Program and Abstracts of the Thirty-Third Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1993. Abstract 232. American Society for Microbiology, Washington, DC.
3. Goldman, R. C., Zakula, D., Flamm, R., Beyer, J. & Capobianco, J. (1994). Tight binding of clarithromycin, its 14(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrobial Agents and Chemotherapy 38, 1496-500.
4. Gustavson, L. E., Kaiser, J. F., Edmonds A. L., Locke, C. S., DeBartolo, M. L. & Schneck, D. W. (1995). Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrobial Agents and Chemotherapy 39, 2078-83.
5. Hardy, D. J., Guay, D. R. P. & Jones, R. N. (1992). Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview. Diagnostic Microbiology Infectious Disease 15, 39-53.
6. Hardy, D. J., Hanson, C. W., Hensey, D. M., Beyer, J. M. & Fernandes, P. B. (1988). Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. Journal of Antimicrobial Chemotherapy 22, 631-6.
7. Hentschel, E., Brandstatter, G., Dragosics, B., Hirschl, A. M., Nemec, H., Schutze, K., et al. (1993). Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. New England Journal of Medicine 328, 308-12.
8. Logan, R. P. H., Bardhan, K. D., Celestin, L. R., Theodossi, A., Palmer, R. K., Reed, P. I., et al. (1995). Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer; a randomised, double-blind, multicentre trial of omeprazole with or without clarithromycin. Alimentary and Pharmacological Therapy 9, 417-23.
9. Marshall, B. J., Goodwin, C. S., Warren, J. R., Murray, R., Blincow, E. D., Blackbourn, S. J. et al. (1988). Prospective double-blind trial of duodenal ulcer response after eradication of Campylobacter pylori. Lancet ii, 1437-42.
10. Marshall, B. J. & Warren, R. H. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i, 1311-5.
11. Millar, M. R. & Pike, J. (1992). Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori. Antimicrobial Agents and Chemotherapy 36, 185-7.
12. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Third Edition. Approved Standard M7-A2. NCCLS, Villanova, PA.